| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.14 | 0.4 |